Wednesday, June 19, 2019

Cerebrospinal Fluid (CSF) Management Market Size, Status, Share And Forecast By 2026


The Cerebrospinal Fluid Management market was valued at USD 1.45 Billion in 2018 and is expected to reach USD 2.11 Billion by 2026, at a CAGR of 4.7% during the forecast period. The increase in investment in research and development in the field of cerebrospinal fluid management and increasing geriatric population worldwide are key factors driving the growth of the market for managing cerebrospinal fluids.
One of the biggest limitations is the inability to produce in the required amount of time a sufficient number of trained neurosurgeons. This lack of trained neurochirurgical professionals extends to North America, Europe, Asia Pacific, Latin America, and Africa.
Further key findings from the report suggest
  • The Cerebrospinal Fluid Management market was valued at USD 1.45 Billion in 2018 and is expected to reach USD 2.11 Billion by 2026, at a CAGR of 4.7% during the forecast period. The increase in investment in research and development in the field of cerebrospinal fluid management and increasing geriatric population worldwide are key factors driving the growth of the market for managing cerebrospinal fluids.
  • The market for hospitals is expected to grow the largest and is estimated to reach at USD 781.5 Million in 2026, at a CAGR of 5.4%, owing to large number of in-hospital cases related to cerebrospinal fluid management in elderly population. The market for Ambulatory Surgical Centers and Diagnostic Centers is expected to grow at the highest CAGR of 6.1% during the forecast period owing to the low cost in relation with surgery in the facility.
  • The key players in the market are Dispomedica (Germany), Sophysa (France), Spiegelberg GmbH (Germany), Medtronic plc (Ireland), Integra LifeSciences (US), B. Braun (Germany), DePuy Synthes (US), Argi Grup (Turkey), Moller Medical (Germany), Sophysa (France and others.
Segments covered in the report:
This report forecasts volume and revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the market on the basis of types, end use, patient type and regional analysis.
Types (Revenue, USD Million; 2016-2026)
  • Shunts
    • Ventriculoperitoneal Shunts
    • Ventriculoatrial Shunts
    • Lumboperitoneal Shunts
    • Ventriculopleural Shunts
    • Fixed Valve Shunts
    • Adjustable Valve Shunts
  • External Drainage Systems
    • External Ventricular Drainage Systems
    • Lumbar Drainage Systems
End Use (Revenue, USD Million; 2016-2026)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
Patient Type (Revenue, USD Million; 2016-2026)
  • Pediatric
  • Adult
  • Geriatric
Region (Thousand, Units and Revenue, USD Million; 2016-2026)
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa

No comments:

Post a Comment

The Alarming Increase in Incidences of Stroke is Boosting the Adoption of Neurovascular Devices

Neurovascular disorders are the second most leading causes of death worldwide after heart diseases. Statistical data suggest a high number o...